Fundraising FoxMeditope Biosciences
Pasadena, US · Founded 2011 · Delaware corporation
Find your way into Meditope Biosciences
Sign up to see every warm intro you have to Meditope Biosciences
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Meditope Biosciences team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Meditope is a biotechnology company developing SnAP technology for antibody design, with a focus on creating more efficacious, safer, and cost-efficient antibody-based therapeutic products.
Founders & leadership
ML
Martin LatterichPresident, CEO, Director
RP
Robert P. McKenzieExecutive Vice President of Business Development, Director
DS
David StoverChief Scientific Officer, Director
SH
Stephanie HsiehNamed on SEC filing
Board
HW
Heng Wei ChangBoard director
GP
George PrendergastBoard director
MG
Michael GoldbergBoard director
RK
Rob KramerBoard director
Reported raises · per SEC filings
Form D private placements$1.6M disclosed across 1 round · 2015
▶$1.6MraisedOct 2015 · 23 investors · BiotechnologyRule 506(b)
▶$1.6MraisedOct 2015 · 23 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Stephanie HsiehExecutive Officer, Director
- Heng Wei ChangDirector
- Robert McKenzieDirector
- George PrendergastDirector
- Michael GoldbergDirector
- Rob KramerDirector
- Offering amount
- $5M
- Amount sold
- $1.6M
- First sale
- Sep 2015
- Incorporated
- Corporation, Delaware, 2011
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- What does Meditope Biosciences do?
- Meditope is a biotechnology company developing SnAP technology for antibody design, with a focus on creating more efficacious, safer, and cost-efficient antibody-based therapeutic products.
- How much funding has Meditope Biosciences raised?
- Meditope Biosciences has disclosed $1.6M raised across 1 round.
- Where is Meditope Biosciences headquartered?
- Meditope Biosciences is headquartered in Pasadena, US.